Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jessica M. Fogel(Johns Hopkins University), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Deborah Persaud(Johns Hopkins University), John W. Mellors(Textron Systems (United Kingdom)), Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Elias K. Halvas(University of Pittsburgh), Scott Rose(Family Health International 360), Sinéad Delany‐Moretlwe(University of Cape Town), Susan H. Eshleman(Johns Hopkins University), Ryan Kofron(APLA Health), Mark A. Marzinke(Family Health International 360), Alex R. Rinehart, Estelle Piwowar-Manning(Johns Hopkins University), Mina C. Hosseinipour, Paul A. Richardson(Johns Hopkins University), Adeola Adeyeye(National Institutes of Health)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k